AI In Patient Engagement Market Size is Predicted to Witness 21.2% CAGR till 2030

 The global AI In Patient Engagement Market size is expected to reach USD 23.1 billion by 2030, registering a CAGR of 21.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the growing demand for AI-based personalized treatment plans and healthcare experiences and the emergence of digital platforms and necessity for omnichannel approach. In addition, the increasing role of artificial intelligence (AI) in enhancing pharmacy efficiency and managing supply chain complexities and business strategies by market players is also driving the market growth. For instance, in May 2024, EmpiRx Health introduced Clinically, a new AI-powered platform that incorporates established technologies. This platform enhances pharmacy claims processing and clinical evaluations and includes a unique population health engine, reinforcing EmpiRx Health's clinical-focused Pharmacy Benefit Management (PBM) approach.

Moreover, the growing prevalence of chronic diseases, such as diabetes and hypertension, necessitates continuous patient engagement & management, which AI can effectively facilitate. Furthermore, AI technologies such as machine learning and natural language processing (NLP) can significantly enhance patient engagement by providing personalized support & interventions. These technologies analyze patient data to offer tailored recommendations, reminders, & educational content, improving adherence and health outcomes. For instance, in March 2022, Uniphore entered into a strategic partnership with SpinSci Technologies, a provider of digital patient engagement solutions, to improve patient access and interaction with healthcare providers. This collaboration integrated Uniphore’s conversational AI and automation technology into SpinSci Technologies Patient Access Care solutions, which are compatible with Electronic Health Records (EHR) systems. The integration aimed to enhance efficiency for contact center agents and streamline patient self-service workflows.

The integration of AI enables healthcare organizations to deliver tailored educational content based on individual patient preferences, health literacy levels, and language proficiency, thereby improving patient engagement & adherence to treatment plans. For instance, in February 2024, Ascend, a startup platform backed by the Accolade Group, announced its intention to deliver educational and healthcare services tailored to specific requirements utilizing AI. As a result of such initiatives, the patient education functionality segment is expected to witness substantial growth, driving overall market expansion in the coming years.

In addition, the market in North America is driven by the integration of AI, enabling healthcare organizations to deliver tailored educational content based on individual patient preferences, health literacy levels, and language proficiency, thereby improving patient engagement & adherence to treatment plans. For instance, in February 2024, Ascend, a startup platform backed by the Accolade Group, announced its intention to deliver educational and healthcare services tailored to specific requirements utilizing AI. As a result of such initiatives, the patient education functionality segment is expected to witness substantial growth, driving overall market expansion in the coming years.

List of Key Players in the AI In Patient Engagement Market

• Medadvisor Solutions
• Innovaccer, Inc.
• EnlivenHealth
• EmpiRx Health, LLC.
• IBM
• Huma
• mPulse Mobile
• AllazoHealth
• P360
• Brand Engagement Network, Inc.
• Oracle
• Nuance Communications, Inc. (Microsoft)
• Health Catalyst
• Ada Health GmbH
• Aiva, Inc.
• Claritas Rx
• AiCure
• UST Global Inc
• ZS
• IQVIA Inc

Related Press Release @ AI In Patient Engagement Market Analysis

AI In Patient Engagement Market Report Highlights

• On the basis of delivery mode, the cloud-based segment dominated the market and held a revenue share of 72.37% in 2023. Cloud-based solutions provide scalable resources, enabling healthcare organizations to adjust capacity according to demand fluctuations
• On the basis of functionality, enhanced communication held the largest revenue share of 25.84% in 2023. The growing integration of AI-driven solutions in the healthcare sector is driving the need for enhanced communication capabilities
• On the basis of technology, Natural Language Processing (NLP) held the largest revenue share of 88.82% in 2023. The segment growth can be attributed to several benefits offered by NLP models such as improved patient engagement and education through the provision of tailored & comprehensible health information
• On the basis of therapeutic area, chronic disease management held the largest revenue share of 64.87% in 2023. The segment growth can be attributed to the increasing prevalence of chronic conditions such as diabetes, hypertension, and heart disease
• On the basis of end use, the healthcare providers segment held the largest revenue share of 38.31% in 2023. The increasing focus on patient-centric care, coupled with the growing need for effective use of resources and a rising demand for personalized healthcare experiences, is driving healthcare providers to adopt AI for patient engagement
• North America dominated the market with a share of 43.60% in 2023. Key factors contributing to this notable share include the presence of a well-established healthcare infrastructure equipped with advanced technology, increasing awareness of the advantages of integrating AI-enabled patient engagement solutions, and a growing preference for personalized healthcare experiences & treatment plans
• The market is fragmented owing to the presence of several players. This is expected to intensify the competition in the coming years. Key companies are increasingly adopting strategies such as new product development, collaborations, and mergers & acquisitions to strengthen their market position. In June 2024, MedAdvisor Solutions announced the launch of Omnichannel Engagement for Pharmacy powered by THRiV, its AI-enabled platform. This suite enables pharmacies to enhance their digital patient engagement strategies and existing initiatives, including providing paperless options increasingly preferred by patients

Request a free sample copy or view report summary: AI In Patient Engagement Market Report

AI In Patient Engagement Market Segmentation

Grand View Research has segmented the global AI in patient engagement market based on delivery mode, functionality, technology, therapeutic area, end use, and region:

AI In Patient Engagement Delivery Mode Outlook (Revenue, USD Million, 2018 - 2030)

• Cloud-based
• On-premise

AI In Patient Engagement Functionality Outlook (Revenue, USD Million, 2018 - 2030)

• Enhanced Communication
• Patient Education
• Chatbots and Virtual Health Assistants
• Predictive Analytics
• Administrative and Streamlined Operations
• Others

AI In Patient Engagement Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Natural Language Processing (NLP)
• Smart Assistance
• OCR (Optical Character Recognition)
• Auto Coding
• Text Analytics
• Speech Analytics
• Classification and Categorization
• Others

AI In Patient Engagement Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)

• Health & Wellness
• Chronic Disease Management
• Others

AI In Patient Engagement End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Healthcare Providers
• Healthcare Payers
• Others (Pharmaceutical Companies, Pharmacy)

AI In Patient Engagement Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Explore Horizon, the world's most expansive market research database

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

PTA Balloon Catheter Market To Reach $4.63 Billion By 2030

 The global PTA Balloon Catheter Market size is expected to reach USD 4.63 billion by 2030, registering a CAGR of 8.32% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing incidence of peripheral artery disorder and the rising number of Percutaneous Coronary Intervention (PCI) procedures in developing countries are key factors driving the market.

The adoption of a sedentary lifestyle by most of the population has increased the prevalence rate of various types of cardiovascular diseases worldwide. An increase in the number of cases of cardiovascular diseases across the globe is expected to boost the adoption of various procedures-such as cardiac catheterizations, angioplasty, and Percutaneous Coronary Intervention (PCI)-to treat such conditions, wherein PTA balloon catheters are among the essential requirements.

The COVID-19 pandemic resulted in a decline in the number of patient encounters, leading to a reduction in the demand for surgical procedures, thereby impacting the industry growth. According to Elsevier, the number of coronary angioplasty surgeries was 11.2% in 2020, which is lower than the previously reported data. According to the National Library of Medicine, the U.S. witnessed a 52.7% decline in adult cardiac surgeries in 2020. In the later phase, as the restrictions were lifted in several countries, the volume of cardiac and peripheral surgical procedures increased. This is expected to increase the demand for angioplasty surgical devices such as PTA balloon catheters.

List of Key Players in PTA Balloon Catheter Market

• Medtronic
• Tuermo Corporation
• Cardinal Health
• Boston Scientific Corporation.
• Natec Medical
• Cook Medical
• Biotronik
• Surmodics, Inc.
• Andratec

Request a free sample copy or view the report summary: PTA Balloon Catheter Market Report

PTA Balloon Catheter Market Report Highlights

• North America market dominated with a share of 47.95% in 2023. This can be attributed to the higher product availability, high demand for surgical procedures, and better awareness in the region
• Asia Pacific is expected to exhibit the fastest growth rate during the forecast period due to government initiatives and increasing incidence of target disorders
• Supportive government regulations to commercialize medical devices in Latin America are expected to impel industry growth. For instance, most Latin American countries only require the U.S. FDA or CE mark approval for filing marketing approvals
• Incorporation of the latest health technologies, partnerships and collaborations, product expansion, and mergers & acquisitions are some of the strategies being adopted by key players to gain a competitive edge in the market. For instance, in February 2022, Boston Scientific Corporation acquired Baylis Medical Company, Inc., a medical device company primarily providing solutions to support catheter-based left heart procedures
• The shortage of cardiac surgeons worldwide is a big concern. Low-income countries are facing this issue more severely. For instance, North Africa has only one surgeon per 1.1 million people. This is resulting in restricting the number of surgeries that could be performed, hindering industry growth

Related Press Release@ PTA Balloon Catheter Material Industry Analysis

PTA Balloon Catheter Market Report Scope

Report Attribute	Details
Market size value in 2024	USD 2.87 billion
Revenue forecast in 2030	USD 4.63 billion
Growth Rate	CAGR of 8.32% from 2024 to 2030
Actual data	2018 - 2023
Forecast period	2024 - 2030

 

PTA Balloon Catheter Market Segmentation

Grand View Research has segmented the global PTA balloon catheter market on the basis of on material type, application, end-use, and region:

PTA Balloon Catheter Material Type Outlook (Revenue, USD Million, 2018 - 2030)

• Polyurethane
• Nylon
• Others

PTA Balloon Catheter Application Outlook (Revenue, USD Million, 2018 - 2030)

• Peripheral Artery Disease
• Coronary Artery Disease

PTA Balloon Catheter End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital
• Ambulatory Surgical Centers
• Others

PTA Balloon Catheter Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• U.K.
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• South Korea
• Australia
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Explore Horizon, the world's most expansive market research database

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Surgical Robots Market by Smith & Nephew; Medrobotics corporation; TransEnterix Surgical, Inc.; Intuitive Surgical

 

The global Surgical Robots Market size is expected to reach USD 7.42 billion by 2030 and is expected to grow at a CAGR of 9.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. Surgical robotic systems are equipped with high-definition cameras and robotic arms, allowing surgeons to perform complicated procedures with enhanced accuracy. The market has grown substantially due to rising demand for minimally invasive surgeries, need for improved surgical outcomes, and continuous evolution of robotic technology. As the healthcare landscape embraces innovation, surgical robots are increasingly becoming a vital tool, revolutionizing surgical approaches and contributing to better patient care.

Moreover, increasing penetration of international players in various regions is expected to boost market growth. COVID-19 outbreak significantly influenced the uptake and integration of surgical robots. Supply chain disruptions and extensive lockdowns across key nations had a notable impact on market growth. An overall decline in surgical procedure volumes due to the pandemic and stringent regulations contributed to the downturn in 2020. As circumstances move closer to pre-pandemic norms, the market is poised for substantial growth.

In addition, collaborative efforts between governments, hospitals, and medical device companies create a favorable environment for product adoption, propelling market growth. For instance, in August 2023, The CK Birla Group partnered with 'Intuitive India' to introduce their Da Vinci Surgical Robot. This collaboration encompasses extensive technology training and assistance from Intuitive India, focusing on enhancing skills of senior surgeons at hospitals. In April 2023, during a symposium on Robotic Colorectal Cancer hosted by the Association of Colon and Rectal Surgeons of India, Apollo Cancer Centers introduced the latest fourth generation Da Vinci Xi Robotic System.

List of Key Players in the Surgical Robots Market

• Intuitive Surgical
• Medrobotics Corporation
• Medtronic
• Renishaw plc
• Smith and Nephew
• Stryker Corporation
• THINK Surgical, Inc.
• TransEnterix (Asensus Surgical, Inc.)
• Zimmer Biomet Holdings, Inc.

Related Press Release@ Surgical Robots Market Report

Surgical Robots Market Report Highlights

• Based on application, others segment accounted for a revenue share of 44.6% in 2023 due to increased usage of advanced automated instruments in cancer and high demand for minimally invasive laparoscopic surgeries
• Based on end-use, inpatient facilities segment held the largest revenue share of 53.21% in 2023 due to high financial resources and patient volume to justify the investment in costly surgical robotic systems
• North America accounted for the largest revenue share of 49.9% in 2023, owing to the strong presence of international players, a lineup of several U.S. FDA clearance products, ongoing robotics developments, and demand for minimally invasive surgeries to reduce the post-operative period

Surgical Robots Market Report Scope

Report Attribute	Details
Market size value in 2024	USD 4.31 billion
Revenue forecast in 2030	USD 7.42 billion
Growth rate	CAGR of 9.5% from 2024 to 2030
Base year for estimation	2023
Historical data	2018 - 2022
Forecast period	2024 - 2030

 

Surgical Robots Market Segmentation

Grand View Research has segmented the global surgical robots market based on application, end-use, and region:

Surgical Robots Application Outlook (Revenue, USD Million, 2018 - 2030)

• Orthopedics
• Knee
• Hip
• Spine
• Others
• Neurology
• Urology
• Gynecology
• Others

Surgical Robots End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Inpatient
• Outpatient

Surgical Robots Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Italy
• France
• Spain
• Denmark
• Sweden
• Norway
• Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Explore Horizon, the world's most expansive market research database

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com